选择性5-羟色胺再摄取抑制剂与危重症成人谵妄的关联:ICU幸存者神经心理功能障碍危险因素与发生率研究的二次分析
该研究为回顾性队列研究,利用Bringing to Light the Risk Factors and Incidence of Neuropsychologic Dysfunction in ICU Survivors数据集,纳入2007年3月至2010年5月入住两个美国ICU的821例呼吸衰竭或休克危重症成人。暴露为ICU内SSRI给药,主要结局为ICU期间每日谵妄或昏迷发生率。调整多种混杂因素后,SSRI给药与次日谵妄/昏迷风险降低相关(OR 0.75;95%CI 0.57-1.00),当日给药亦与风险降低相关(OR 0.66;95%CI 0.50-0.87)。作者结论认为SSRI给药与24小时内及当日谵妄/昏迷风险降低相关。
要点
- 在821例呼吸衰竭或休克ICU患者中,233例(28.4%)在ICU期间至少接受过一次处方SSRI。
- 调整混杂因素后,ICU内SSRI给药与次日谵妄/昏迷风险降低相关(OR 0.75;95%CI 0.57-1.00)。
- 同日给予SSRI亦与谵妄/昏迷风险降低相关(OR 0.66;95%CI 0.50-0.87)。
- ICU住院期间,606例(74%)患者曾出现谵妄,532例(64.8%)曾出现昏迷。
- 该研究为回顾性队列二次分析,结果仅提示关联,不能确立因果关系。
适用人群与场景
- 2007年3月至2010年5月入住两个美国内科或外科ICU的危重症成人,入组时存在呼吸衰竭或休克。
研究设计与关键结果
- 研究类型:基于Bringing to Light the Risk Factors and Incidence of Neuropsychologic Dysfunction in ICU Survivors数据集的回顾性队列研究二次分析,纳入821例患者,来自两个美国ICU。
- 人群中位年龄61.2岁(四分位距50.9-70.7),女性401例(48.8%)。
- 233例(28.4%)在ICU期间至少接受过一次处方SSRI。
- ICU住院期间606例(74%)曾出现谵妄,532例(64.8%)曾出现昏迷。
- 调整多种潜在混杂因素后,ICU内SSRI给药与次日谵妄/昏迷风险降低相关(OR 0.75;95%CI 0.57-1.00)。
- 同日给予SSRI亦与谵妄/昏迷风险降低相关(OR 0.66;95%CI 0.50-0.87)。
证据类型、等级与局限
- 证据类型:回顾性队列研究(二次分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在内科或外科ICU的危重症患者中,SSRI给药与24小时内及给药当日谵妄/昏迷风险降低相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the association between selective serotonin reuptake inhibitors (SSRI) and delirium in the subsequent 24 hours after drug administration in critically ill adults.
DESIGN: Retrospective cohort study utilizing the Bringing to Light the Risk Factors and Incidence of Neuropsychologic Dysfunction in ICU Survivors dataset.
SETTING: Two large U.S. ICUs.
PATIENTS: Critically ill adults admitted to a medical or surgery ICU between March 2007 and May 2010 with respiratory failure or shock.
INTERVENTIONS: Our primary outcome was the occurrence rate of delirium or coma during each day in the ICU. Our exposure variable was SSRI administration on the prior day in the ICU. As a secondary question, we assessed the association of SSRI administration and delirium the same day of SSRI administration in the ICU.
MEASUREMENTS AND MAIN RESULTS: We analyzed 821 patients. The median age was 61.2 years old (interquartile range, 50.9-70.7), and 401 (48.8%) were female. A total of 233 patients (28.4%) received prescribed SSRIs at least once during their ICU admission. Delirium was present in 606 (74%) of the patients at some point during hospitalization in the ICU. Coma was present in 532 (64.8%) of the patients at some point during hospitalization in the ICU. After adjusting for multiple potential confounding factors, we found that SSRI administration in the ICU was associated with lower odds of delirium/coma (odds ratio [OR], 0.75; 95% CI, 0.57-1.00) the next day. An SSRI administered on the same day reduced the odds of delirium/coma as well (OR, 0.66; 95% CI, 0.50-0.87).
CONCLUSIONS: SSRI administration is associated with decreased risk of delirium/coma in 24 hours and on the same day of administration in critically ill patients in a medical or surgical ICU.
参考来源
- Austin CA, Yi J, Lin FC, et al. The Association of Selective Serotonin Reuptake Inhibitors With Delirium in Critically Ill Adults: A Secondary Analysis of the Bringing to Light the Risk Factors and Incidence of Neuropsychologic Dysfunction in ICU Survivors ICU Study. Crit Care Explor. 2022. PMID: 35923593. doi:10.1097/CCE.0000000000000740
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。